Related Experiment Video
Updated: May 13, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Redefining classification of central neck dissection in differentiated thyroid cancer
Edward D McAlister1, David P Goldstein, Lorne E Rotstein
1Department of Surgical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Head & Neck
|March 20, 2013
Summary
A new classification system for central neck dissection in differentiated thyroid cancer is proposed. This system aims to standardize reporting and improve comparisons of surgical strategies for lymph node removal.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Therapeutic central neck dissection is standard for differentiated thyroid cancer with clinically positive lymph nodes.
- The extent of lymphadenectomy in clinically negative disease remains controversial, leading to surgical variability.
- Current descriptions of central neck boundaries and dissection components are inconsistent.
Purpose of the Study:
- To introduce a novel classification system for central neck dissection in thyroid cancer.
- To standardize the reporting of surgical extent in the central neck compartment.
- To facilitate objective comparisons between different lymphadenectomy strategies.
Main Methods:
- Development of a novel classification system for central neck dissection.
- Defining clear boundaries and components for central neck dissection.
- Proposing a system for accurate documentation of lymphadenectomy extent.
Main Results:
- The proposed classification system allows for precise reporting of the extent of central neck dissection.
- It addresses the variability in describing central neck boundaries and dissection components.
- Enables clearer distinction between comprehensive and less extensive dissections.
Conclusions:
- A standardized classification system is crucial for accurate reporting in central neck dissection for thyroid cancer.
- This system will reduce ambiguity in the literature and aid in comparing surgical outcomes.
- Facilitates better understanding and management of differentiated thyroid cancer treatment.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

